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The coronavirus spike (S) protein, required for receptor binding and membrane fusion, is incorporated into the assembling virion by
interactions with the viral membrane (M) protein. Earlier we showed that the ectodomain of the S protein is not involved in this process. Here
we further defined the requirements of the S protein for virion incorporation. We show that the cytoplasmic domain, not the transmembrane
domain, determines the association with the M protein and suffices to effect the incorporation into viral particles of chimeric spikes as well as
of foreign viral glycoproteins. The essential sequence was mapped to the membrane-proximal region of the cytoplasmic domain, which is
also known to be of critical importance for the fusion function of the S protein. Consistently, only short C-terminal truncations of the S
protein were tolerated when introduced into the virus by targeted recombination. The important role of the about 38-residues cytoplasmic
domain in the assembly of and membrane fusion by this approximately 1300 amino acids long protein is discussed.
D 2005 Elsevier Inc. All rights reserved.
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In infected cells viruses are assembled from a heteroge-
neous pool of viral and cellular proteins. The preferential
incorporation of viral proteins from this pool into virions is
achieved mainly by affinity interactions and by the local
concentration of these proteins at the site of assembly. For
enveloped viruses, the specificity of the assembly process is
governed by interactions between the viral membrane
proteins and with the nucleocapsid or the matrix proteins.
In this study we focus on the assembly requirements of the
coronavirus spike glycoprotein into the virion membrane.
Coronaviruses have a relatively simple protein compo-
sition. The nucleocapsid protein packages the viral RNA
genome into a helical nucleocapsid, which is in turn
surrounded by a lipid envelope. The envelope accommo-
dates three or four viral membrane proteins: the most0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: p.rottier@vet.uu.nL (P.J.M. Rottier).abundant triple-spanning membrane (M) protein, the large
trimeric spike (S) glycoprotein, and the low-abundant
envelope (E) protein. Some coronaviruses contain an
additional membrane protein, the hemagglutinin–esterase
(HE) protein. Coronaviruses acquire their lipid envelope by
budding of the nucleocapsid into the membranes of the
intermediate compartment (Corse and Machamer, 2000;
Klumperman et al., 1994; Krijnse-Locker et al., 1994; Tooze
et al., 1984, 1988).
The M protein is the key player in coronavirus particle
formation (reviewed by Rottier, 1995a). When expressed
independently in eukaryotic cells it interacts with itself
forming homomultimeric complexes (Locker et al., 1995).
Upon co-expression with the E protein, these complexes
assemble into virus-like particles (VLPs) which are similar
to authentic virions in size and shape, demonstrating that the
M and E proteins are the minimal requirements for envelope
assembly (Vennema et al., 1996). Incorporation of the
nucleocapsid is mediated by interactions with the M protein
(Haijema et al., 2003; Kuo and Masters, 2002; Narayanan05) 306–318
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incorporation of the S protein (de Haan et al., 1999; Nguyen
and Hogue, 1997; Opstelten et al., 1995; Vennema et al.,
1996) and the HE protein (Nguyen and Hogue, 1997) into
virions and VLPs.
The mouse hepatitis virus (MHV) spike glycoprotein is
responsible for binding of the virus to the host cell receptor
and for virus–cell as well as cell–cell fusion (reviewed by
Cavanagh, 1995). It is a 1324 amino acids (aa) type I
membrane glycoprotein (Mw 180 kDa) consisting of a large
ectodomain (1263 aa), a transmembrane domain (TM; ~23
aa), and a short cytoplasmic domain (CD; ~38 aa). It is co-
translationally glycosylated in the ER and oligomerizes into
trimers (Delmas and Laude, 1990). A fraction of the spikes is
transported to the cell surface where it induces cell–cell
fusion. Upon passage through the Golgi compartment, the
spike protein is post-translationally cleaved (Luytjes et al.,
1987; Sturman et al., 1985) into a soluble – receptor binding –
S1 subunit (Suzuki and Taguchi, 1996) and a membrane
anchored – membrane fusion – S2 subunit (Yoo et al., 1991)
of about equal size (90 kDa). As demonstrated by co-
immunoprecipitation assays, the majority of the spike protein
in infected cells is retained in the ER where it associates with
the M protein via heterotypic affinity interactions (Opstelten
et al., 1995). These interactions are virus specific, M and S
proteins from different (e.g., feline and murine) coronavi-
ruses do not associate. The spike ectodomain is not
responsible for the interaction with the M protein; when the
MHV S ectodomain was replaced by that of feline infectious
peritonitis virus (FIPV) the chimeric S protein associated
with the MHV but not with the FIPV M protein and was
incorporated into MHV-based, not FIPV-based VLPs; the
reciprocal chimeric protein behaved inversely (Godeke et al.,
2000a). These chimeric spike proteins were functionally
incorporated into recombinant MHVand FIPV, respectively,
providing the resulting viruses fMHV and mFIPV with
opposite targeting specificities (Haijema et al., 2003; Kuo et
al., 2000). The observations imply that sequences in the TM
and/or the CD of the spike protein mediate interaction with
the M protein and envelope incorporation.
In the present work we have determined the sequences in
the coronavirus S protein that are involved in M protein
interaction and required for spike assembly into the virion.
Using co-immunoprecipitation and VLP formation assays in
combination with targeted RNA recombination in a muta-
genic analysis, the critical domain was mapped to the
membrane-proximal, cysteine-rich part of the S protein.Results
The cytoplasmic domain is required for S protein particle
assembly
To identify the sequences in the TM and/or CD that
control the S protein’s virion assembly, we constructedchimeric spike proteins of which either the TM (MFM) or
the CD (MMF) of MHV S was replaced by a corresponding
domain of FIPV S (Fig. 1). In the three-letter designation of
the constructs the first letter refers to the viral origin of the
ectodomain, the second and third letters indicate the origin
of TM and CD, respectively. In the chimeric MFF and MFM
gene, the transition from the MHV S ectodomain to the
FIPV S TM was at the highly conserved KWPW(W/Y)
VWL amino acid sequence motif (Fig. 1A). The junction
between the TM and the CD in the MFM and MMF
chimeras was at the conserved TGC motif occurring in the
cysteine-rich region (Fig. 1). The proper folding, transport
to the plasma membrane, and membrane fusion capacity of
the chimeric proteins MFF, MFM, and MMF were
confirmed by looking at their acquisition of endoglycosi-
dase H (endoH) resistance, their cell surface expression, and
their cell–cell fusion induction, respectively (data not
shown). To evaluate the ability of the recombinant S
proteins to interact intracellularly with the M protein we
employed a previously developed co-immunoprecipitation
assay (Opstelten et al., 1995). In addition, assembly of the
recombinant spike proteins into VLPs was examined using a
VLP affinity-isolation assay (de Haan et al., 2000). Thus,
the MHV M and E protein were co-expressed using the
vaccinia virus expression system in OST7-1 cells in
combination with either the MHV S protein or the MFF,
MFM, or MMF S proteins. Cells were radiolabeled from 6
to 9 h post-infection (pi) after which cell lysates and media
were prepared and subjected to coIP and VLP affinity
isolation, respectively, with either the anti-MHV serum or
the anti-S mAb (Fig. 2). The intracellular expression of the
M protein and the (recombinant) S proteins was confirmed
by immunoprecipitation with the anti-MHV serum (Fig.
2A). The immunoprecipitation performed on cell lysates
expressing the MHV M + E + S proteins using the anti-S
mAb not only brought down the S protein but, as
anticipated, also the MHV M protein, indicating that the
proteins occurred in association (positive control). The
chimeric proteins MFF and MMF, both containing the CD
of FIPV S, did not interact with the MHV M protein, as
judged from the absence of co-precipitation (negative
control). In contrast, the M protein was co-precipitated
when co-expressed with the MFM chimera, indicating that
the CD of MHV S is required for the interaction and that
replacement of just the transmembrane domain of MHV S
by that of FIPV S does not affect this interaction. The
assembly of the MHV-FIPV S chimeric proteins into viral
particles was examined by performing affinity-isolations of
VLPs present in the culture media (Fig. 2B). VLPs were
formed whenever the MHV M and E protein were co-
expressed, as shown by the presence of the M protein in
immuno-isolations done with the anti-MHV serum. Co-
purification of M from the culture media using the anti-S
mAb was observed when the M and E proteins were co-
expressed with either the MHV S protein or the chimeric
protein MFM, but not with the MFF and MMF chimeras.
Fig. 1. (A) A CLUSTALW alignment of the carboxy-terminal spike protein sequences from nine coronaviruses including feline infectious peritonitis virus
(FIPV, strain 79-1146; GenBank accession no. VGIH79), porcine transmissible gastroenteritis virus (TGEV, strain Purdue; GenBank accession no. P07946),
porcine epidemic diarrhea virus (PEDV; GenBank accession no. NP_598310), HCoV-229E (human coronavirus, strain 229E; GenBank accession no.
VGIHHC), bovine coronavirus (BcoV, strain F15; GenBank accession no. P25190), mouse hepatitis virus (MHV, strain A59; GenBank accession no. P11224),
HCoV-OC43 (human coronavirus, strain OC43; GenBank accession no. CAA83661), SARS-CoV (strain TOR2; GenBank accession no. P59594) and
infectious bronchitis virus (IBV, strain Beaudette; GenBank accession no. P11223). The transmembrane domain and cysteine-rich region are indicated. (B)
Diagrams of wild-type MHV S protein; cytoplasmic domain truncation mutants SD12, SD25, and SD35; MHV-FIPV chimeras MFF, MFM, and MMF; and
VSV G wild-type and VSV-MHV chimeric proteins G-STC and G-SC. Light grey boxes represent the MHV S amino acids sequences, black boxes indicate
FIPV S sequences, whereas the dark grey bars represent sequences of the VSV G. ED, ectodomain; TM, transmembrane domain; CD, cytoplasmic domain.
Below, TM and CD amino acid sequences of all constructs shown above. The cysteine-rich region in the MHV S and MFF protein has been boxed. The MHV
S-derived sequences are indicated in bold. TM regions are underlined.
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co-immunoprecipitation experiments and confirm that the
CD of MHV S is essential for interaction with the MHV M
protein and for its assembly into virus-like particles.
To obtain further confirmation for the essential role of the
S protein CD in these processes we tested the different S
proteins also in a reciprocal system by analyzing their
interaction with the FIPV M protein using the co-immuno-
precipitation assay. The FIPV M and E proteins were co-
expressed using the vaccinia virus expression system with
MHV S or with the MHV/FIPV S chimeras MFF, MFM, orMMF. Radiolabeled viral proteins were immunoprecipitated
from the cell lysates using an anti-FIPV serum and the anti-
S mAb and the precipitates were analyzed by SDS–PAGE
(Fig. 2C). The immunoprecipitation with the anti-FIPV
serum confirmed the intracellular expression of the FIPV M
protein. The anti-S mAb immunoprecipitated the (chimeric)
spike proteins and co-immunoprecipitated the FIPV M
protein but only when co-expressed with the chimeric S
proteins MFF and MMF, both of which contain the CD of
FIPV S. Co-immunoprecipitation of FIPV M protein was
not seen when MHV S or the MFM chimera were
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for the specific interaction with the M protein. Due to the
low yields of FIPV VLPs we were unable to examine the
assembly of the MHV-FIPV S chimeric proteins into viral
particles through VLP affinity isolation.
S protein cytoplasmic domain is sufficient for particle
incorporation
Because coronavirus S protein TM domains are suffi-
ciently conserved (65% identity; Fig. 1A) to potentially
explain the lack of effect of their swapping between MHV S
and FIPV S on the interaction of the S proteins with the Mproteins and on their incorporation into VLPs, we could not
conclude that the CD by itself is responsible for these
observations. To further study the importance of this domain
we investigated whether the MHV S CD is sufficient to
mediate the assembly of a foreign viral membrane protein
into the MHV envelope. Thus we made vesicular stomatitis
virus (VSV) G/MHV S chimeras in which the entire
carboxy-terminal domain (G-STC) or just the CD (G-SC)
of the non-related G protein were replaced by that of MHV
S (Fig. 1B). The chimeric proteins were examined for their
ability to interact with MHV M protein and for their
incorporation into MHV-based VLPs using again the co-
immunoprecipitation and VLP affinity isolation assays. The
MHV M and E protein were co-expressed alone or in
combination with either the wild-type VSV G protein or one
of the chimeric G-STC or G-SC proteins as described
before. Co-immunoprecipitation of radiolabeled viral pro-
teins from the cell lysates and VLP affinity isolation from
the culture media were performed using the anti-MHV
serum or the anti-VSV serum. The SDS–PAGE analyses of
Fig. 3A show that the M protein, the VSV G protein, and the
VSV G/MHV S chimeras were indeed produced. Where the
chimeric proteins were expressed, the anti-VSV serum also
precipitated an approximately 62-kDa protein. Most likely
this protein corresponds to a soluble form of the VSV G/
MHV S chimeras, as has been observed previously for VSV
G in infected cells (Garreis-Wabnitz and Kruppa, 1984;
Graeve et al., 1986). For wt VSV G this protein band was
only apparent in the culture media (data not shown)
indicating that during the chase the soluble form of VSV
G was efficiently secreted. The MHV M protein was co-
immunoprecipitated using the anti-VSV serum when co-
expressed with G-STC and G-SC, but not with wild-type
VSV G. This provides evidence that replacement of just the
CD of VSV G by that of MHV S is sufficient for interaction
with the MHV M protein. Consistently, VLPs could be
affinity isolated from the culture medium using the anti-
VSV serum (Fig. 3B) when the M and E proteins were co-
expressed with G-STC and G-SC but not with the wild-typeFig. 2. Interactions of the wt MHV S protein or the MHV/FIPV S chimeric
proteins MFF, MFM, and MMF with the membrane protein M and their
incorporation into VLPs. (A) Demonstration of intracellular interaction of
the S protein (chimeras) with M. Intracellular expression of the MHV M
and E proteins in combination with the MHV S, MFF, MFM, or MMF
protein. Radiolabeled proteins were immunoprecipitated from the cell
lysate using the anti-MHV serum (a-MHV) or the anti-S monoclonal
antibody (a-S) and analyzed by SDS–PAGE. (B) Demonstration of
(chimeric) S protein incorporation into VLPs. Culture media were
collected, processed for affinity isolation of radiolabeled VLPs using the
anti-MHV serum (a-MHV) or the anti-S monoclonal antibody (a-S), and
the samples were analyzed by SDS–PAGE. The molecular mass markers
are indicated on the left. Arrows on the right indicate the positions of the
expressed proteins. (C) Interactions of the (chimeric) spike protein with the
FIPV membrane protein M. Intracellular expression of the FIPV M and E
proteins in combination with the MHV S, MFF, MFM, or MMF protein.
Radiolabeled proteins were immunoprecipitated from the cell lysate using
the anti-FIPV serum (a-FIPV) or the monoclonal antibody to MHV S (a-S)
and analyzed by SDS– PAGE.
Fig. 3. Interactions of the wt VSV G or the VSV-G/MHV-S chimeric
proteins G-STC and G-SC with the membrane protein M and their
incorporation into VLPs. (A) Demonstration of intracellular interaction of
the (chimeric) VSV G with M. Intracellular expression of the MHVM and E
proteins in combination with the VSV G, G-STC, and G-SC protein.
Radiolabeled proteins were immunoprecipitated from the cell lysate using
the anti-MHV serum (a-MHV) or the anti-S monoclonal antibody (a-S) and
analyzed by SDS–PAGE. (B) Demonstration of (chimeric) S protein
incorporation into VLPs. Culture media were collected, processed for
affinity isolation of radiolabeled VLPs using the anti-MHV serum (a-MHV)
or the anti-S monoclonal antibody (a-S), and the samples were analyzed by
SDS–PAGE. The molecular mass markers are indicated on the left. Arrows
on the right indicate the positions of the expressed proteins.
Fig. 4. Fusion properties of the recombinant spike proteins containing CD
truncations. Subconfluent monolayers of OST7-1 cells were infected with
vTF7.3 and transfected with the plasmids encoding MHV S protein and the
recombinant SD12, SD25, and SD35 CD truncation proteins. At 6 h pi the
cells were overlaid with LR7 cells and at 9 h pi pictures were taken.
B.J. Bosch et al. / Virology 334 (2005) 306–318310VSV G protein, indicating that the S protein transmembrane
domain is not required for interaction with the M protein
and for subsequent VLP incorporation.
Only the membrane-proximal part of the CD is required for
S protein particle assembly
Knowing the importance of the CD for S protein particle
incorporation we wanted to further define this role by
studying a series of increasingly truncated forms of the
protein. The MHV spike protein has a 38-residue CD
containing a conserved cysteine-rich region (boxed
sequence in Fig. 1B). This is probably the region where
palmitoylation of the S protein occurs, while the region has
also been implicated to play a role in membrane fusion (Bos
et al., 1995). Three S protein mutants were constructed in
which the CD was truncated by 12, 25, and 35 residues,
respectively. When expressed in cells the proteins could be
detected at the cell surface by immunofluorescence (data not
shown) indicating their proper transport to the plasma
membrane. Their membrane fusion capacity was tested in a
cell–cell fusion assay (Fig. 4). Truncation of the spike CD
by 12 or 25 residues (SD12 and SD25, respectively) did not
abolish cell–cell fusion, although less fusion was observed
with the SD25 mutant. No cell–cell fusion was seen with the
SD35 mutant supporting the importance of the cysteine-rich
region for membrane fusion. The truncated spike proteins
were then assessed for their interaction with M protein andfor their VLP incorporation by co-expression with the MHV
M and E proteins as described before. The resulting cell
lysates and culture media were subjected to co-immunopre-
cipitation and VLP affinity isolation, respectively, using the
anti-MHV serum and the anti-S mAb followed by SDS–
PAGE analysis. As the co-immunoprecipitation patterns of
Fig. 5A demonstrate, the SD12 protein was able to interact
with the M protein as efficiently as the wild-type S protein,
whereas SD25 and SD35 showed a strong reduction in their
ability to associate with the M protein. Consistently, the
VLP affinity isolation showed the SD12 to be efficiently
incorporated into VLPs whereas VLP inclusion of the spike
mutants lacking the C-terminal 25 and 35 amino acids was
almost completely abolished (Fig. 5B).
Evaluation of the spike cytoplasmic domain truncations in
the context of coronavirus
Next we wanted to investigate to what extent the CD
truncations of the S protein would be tolerated in the context
of the virus by attempting to introduce the spike gene
constructs into the viral genome using targeted RNA
recombination (Fig. 6A). To facilitate the selection of
recombinant viruses through the sensitive detection of
luciferase activity we made use of a transfer vector
containing, in addition to the modifications in the S genes,
the Renilla luciferase gene inserted between the E and the M
gene (MHV-ERLM) (de Haan et al., 2003). We were able to
recover infectious MHV in which the wild-type S gene had
been replaced by the SD12 or the SD25 gene. Despite
several attempts, replacement of the wt S gene by the SD35
gene was never successful and only yielded recombinants
lacking the Renilla luciferase activity, apparently generated
through double recombination. The failure to produce
infectious MHV-ERLM-SD35 virus was not unexpected,
as the truncated SD35 protein had lost the cell–cell fusion
Fig. 5. Interactions of the wt MHV S protein or CD truncation proteins
SD12, SD25, and SD35 with the membrane protein M and their
incorporation into VLPs. (A) Demonstration of intracellular interaction of
the S proteins with M. Intracellular expression of the MHVM and E proteins
in combination with the wt MHV S or SD12, SD25, and SD35 spike CD
truncation proteins. Radiolabeled proteins were immunoprecipitated from
the cell lysate using the anti-MHV serum (a-MHV) or the anti-S monoclonal
antibody (a-S) and analyzed by SDS–PAGE. (B) Demonstration of S protein
incorporation into VLPs. Culture media were collected, processed for
affinity isolation of radiolabeled VLPs using the anti-MHV serum (a-MHV)
or the anti-S monoclonal antibody (a-S), and the samples were analyzed by
SDS–PAGE. The molecular mass markers are indicated on the left. Arrows
on the right indicate the positions of the expressed proteins.
Fig. 6. (A) Plasmid constructs, targeted recombination, and recombi-
nant viruses. The plasmids pXH2ERLM-SD12, -SD25, and -SD35
(see Materials and methods) were used to transcribe the defective
RNAs in vitro by using T7 polymerase. The arrow at the left end of
the vectors indicates the T7 promoter; the solid circle represents the
polylinker between the 5V-end segment of the MHV genome (labeled
5V/1) and the HE gene, which is followed by the structural and group
specific genes, the inserted Renilla luciferase gene (RL), the 3V
untranslated region (UTR), and the polyadenylate segment (labeled
3V/U). The asterisk indicates the position of the S protein cytoplasmic
domain truncations. The lower part shows a scheme for targeted
recombination by using the interspecies chimeric fMHV, which
grows only in feline cells. Recombinant viruses generated by the
indicated crossover event can be selected on the basis of their
ability to grow in murine cells and by the acquired Renilla luciferase
gene. (B) RT-PCR analysis of recombinant MHV-ERLM viruses
with S protein CD truncations. An (RT-)PCR was used to amplify
regions of cytoplasmic viral RNA isolated from cells infected with
MHV-ERLM, MHV-ERLM-SD12 (clones A and B), or MHV-ERLM-
SD25 (clone B). The approximate locations of primers 1036, 1090,
and 1261 in the recombinant MHV genomes are shown. Primer
1261 was used for the RT-step. Primer pair 1036–1090 was used
for the PCR on the RT product and, as a control, on the plasmids
used to make the recombinant viruses (pXH2ERLM, -SD12, and
-SD25). PCR products were analyzed in an agarose gel. The most
intense band of the 100-bp marker represents the 600 bp DNA. The
asterisk marks the position of the S protein cytoplasmic domain
truncations.
B.J. Bosch et al. / Virology 334 (2005) 306–318 311activity. The identity of the MHV-ERLM-SD12 and MHV-
ERLM-SD25 recombinant viruses was examined by RT-
PCR. An RT-PCR was performed on the viral RNA by
amplifying a region covering the CD using a forward primer
located in the ectodomain encoding part of the S gene and a
reverse primer complementary to the ORF 4 gene (Fig. 6B).
For reference purposes, PCRs were also performed on the
transfer vectors used to make the recombinant viruses. The
RT-PCR products obtained with the MHV-ERLM-SD12 and
-SD25 viruses were found to correspond to the sizes of the
PCR products obtained with the corresponding transfer
vectors. Sequence analysis of the RT-PCR products con-
firmed the introduction of the intended spike CD truncation.
The replacement of the wild-type spike gene in the virus
by the truncated SD12 and SD25 genes allowed us to directly
quantitate the effects of CD truncations on virus production.
We first assessed their effect on plaque formation. Plaque size
of the MHV-ERLM-SD12 and -SD25 was measured in LR7
cells relative to the MHV-ERLM. The plaque size of two
independently obtained MHV-ERLM-SD12 recombinant
viruses appeared to be reduced to ~75%, whereas MHV-
ERLM-SD25 recombinant virus showed tiny plaques which
were at ~35% of the MHV-ERLM plaque size (Fig. 7A). The
effect of the truncation in MHV-ERLM-SD12 on the virus
Fig. 7. Growth characteristics and sequence analysis of recombinant
viruses containing S protein CD truncations. (A) Plaque sizes of MHV-
ERLM-SD12 clones A and B, MHV-ERLM-SD25 clone B, MHV-ERLM-
SD25 revertant, and MHV-ERLM-SD25R clones A and B relative to
MHV-ERLM. (B) Single-step growth kinetics of MHV-ERLM-SD12
compared to MHV-ERLM. LR7 cells were infected with either MHV-
ERLM or MHV-ERLM-SD12 clone A or B at an MOI of 5. Viral
infectivities in the culture media at different times post-infection were
determined by a quantal assay on LR7 cells, and the TCID50 values were
calculated. (C) Luciferase detection in infected cell lysates during single-
step growth of MHV-ERLM-SD12 clones A and B compared to MHV-
ERLM. (D) Sequence analysis of MHV-ERLM-SD25 revertant viruses. A
17-nucleotide deletion indicated by a dashed line was observed in the
sequence of two MHV-ERLM-SD25 recombinant viruses that had been
passaged independently for 6 rounds and had regained fitness. The
deletion resulted in an extension of the cytoplasmic domain with 6 amino
acids (SD25R) compared to the original MHV-ERLM-SD25 recombinant
(SD25). The translated amino acid sequences corresponding to the S open
reading frame of the SD25 and SD25R viruses are indicated above and
below the nucleotide sequences, respectively. Stop codons are marked in
bold and by an asterisk.
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growth curve. A comparative analysis with the MHV-
ERLM-SD25 mutant was not feasible, as its severely
impaired growth (maximum titer ~2  102 PFU/ml) and
did not allow production of an amount of virus sufficient
for the experiment. LR7 cells were infected in parallel with
the MHV-ERLM and the independently obtained MHV-
ERLM-SD12 A and B viruses using a high MOI to obtain
a synchronous infection in all cells. Unadsorbed virus was
washed away and virus release was subsequently measured
over time by performing a TCID50 assay (Fig. 7B) and a
luciferase assay (Fig. 7C) with samples taken at different
time points during infection. The luciferase expression
levels obtained with the different viruses were indistin-
guishable, confirming that the same amounts of cells had
been infected. However, the release of infectious MHV-
ERLM-SD12 recombinant viruses was significantly lower
(~1 log) compared to that of the MHV-ERLM virus,
indicating a slight effect of the spike cytoplasmic domain
truncation on virus reproduction. To try obtaining rever-
tants of the MHV-ERLM-SD25 virus with regained
viability we carried out low-multiplicity passaging of the
mutant virus. By passage 6, we observed a more severe and
faster developing cytopathic effect for two independently
passaged viruses. The titers reached with these viruses
were indeed increased significantly, i.e., by about 3 logs
(from 2  102 to 2  105 PFU/ml). To determine the
sequence changes responsible for this gain in fitness, we
sequenced a region of the two MHV-ERLM-SD25 rever-
tants after RT-PCR amplification of genomic viral RNA
with the same primers as used for Fig. 6. Both revertants
showed an identical 17-nucleotide deletion in the S gene 3V
region that deleted the stop codon and resulted in a
predicted 6-residue extension of the cytoplasmic domain
(Fig. 7D). The relative plaque size of the MHV-ERLM-
SD25 revertants was increased compared to that of MHV-
ERLM-SD25 but their size remained smaller than that of
the parental MHV-ERLM. To exclude that other mutations
introduced into the viral genome during passaging were
responsible for the increased growth of the revertant
viruses we introduced the 17-nt deletion into the MHV-
ERLM background. The yields of two independently
obtained MHV-ERLM-SD25R viruses A and B (max titers
2  105 PFU/ml) and the observed plaque sizes of these
viruses (Fig. 7A) were indistinguishable from that of the
MHV-ERLM-SD25 revertants demonstrating that the cyto-
plasmic domain extension was responsible for the reversion
phenotype (Schnell et al., 1998).Discussion
An intriguing question we have addressed in this paper is
how coronaviruses regulate the selective inclusion of the
viral spike protein into their envelope against a huge
background of host membrane proteins. The stringency of
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budding strategy of the viruses, by affinity interactions with
the viral membrane protein M, and by the geometrical
constraints of the viral envelope and particle. That this is a
process of great specificity is illustrated by the fact that
coronaviruses cannot be pseudotyped by spike proteins of
other coronaviruses as was demonstrated for MHV and
FIPV S proteins using VLPs. Only when provided with the
proper, i.e., cognate carboxy-terminal sequence could S
proteins be swapped (Godeke et al., 2000b; Kuo et al.,
2000), indicating that the TM and/or CD are critical for
incorporation into the assembling virion. Here we mapped
the essential sequences to the CD of the S protein. First we
show, by exchanging domains between the S proteins of
MHV and FIPV, that this domain determines its interaction
with the M protein, an association that is key to its assembly.
Then we show that the MHV S protein CD, not its TM,
could confer to the FIPV S protein the ability to become
assembled into MHV particles. Finally, to rule out that a
coronaviral TM is somehow important, we demonstrate that
the MHV S protein CD is sufficient to mediate MHV
particle assembly of a foreign viral membrane protein not
normally incorporated into coronavirus.
Cytoplasmic domains of viral membrane proteins appear
to have important functions in the assembly of many
enveloped viruses. These functions vary, depending on the
particular virus and its way of budding. For alphaviruses, for
instance, where the membrane proteins are unable to effect
budding on their own, the cytoplasmic domain of the E2
glycoprotein plays a critical role in the interaction with the
capsid protein during particle formation (Suomalainen et al.,
1992; Zhao et al., 1994). Paramyxovirus particle assembly
requires the co-expression of the viral matrix protein with
one of the two envelope glycoproteins, HN or F, together
with the nucleocapsid protein (Schmitt et al., 2002). A
critical role for the cytoplasmic tails in this process has been
reported for several members including measles virus
(Cathomen et al., 1998), Sendai virus (Fouillot-Coriou and
Roux, 2000; Takimoto et al., 1998), and Simian virus 5
(SV5) (Schmitt et al., 1999; Waning et al., 2002). In Sendai
virus the matrix protein was shown to interact independently
with the cytoplasmic tails of the HN and F glycoproteins
(Ali and Nayak, 2000; Sanderson et al., 1994). The roles of
the cytoplasmic tails in paramyxovirus assembly seem
redundant as in SV5 the truncation of either of the two
but not of both appeared to be tolerated (Waning et al.,
2002). Such redundancy was also observed with the
orthomyxovirus influenza A where the cytoplasmic tails of
the two glycoproteins, HA and NA, determine budding
efficiency as well as particle morphology. While their
separate removal had only limited effects, the lack of both
tails resulted in severely impaired formation of deformed
particles (Jin et al., 1994, 1997; Mitnaul et al., 1996; Zhang
et al., 2000). For rhabdoviruses and retroviruses (Mebatsion
et al., 1996; Wilk et al., 1992) there is no absolute
requirement for a cytoplasmic domain of their envelopeglycoprotein for assembly. While the G protein tail greatly
enhances VSV production, a strict sequence requirement
does not exist as a G protein with a foreign cytoplasmic tail
of sufficient length could be incorporated efficiently
(Schnell et al., 1998). This G protein tail on the other hand
can specifically direct the incorporation of the HIV-1
envelope protein into VSV particles, which the wild-type
envelope protein does not (Owens and Rose, 1993).
Coronaviral S proteins generally exhibit little sequence
conservation. This is particularly the case for the receptor
binding part S1 where hardly any sequence similarities
occur between proteins from different groups. Regions of
sequence identity of up to approximately 30% are found in
the part responsible for membrane fusion, S2 (Cavanagh,
1995). In the carboxy-terminal domain two areas of
conservation occur. One is at the transition of TM and
ectodomain, i.e., where the S protein exits the viral
membrane. It is characterized by a conspicuous, highly
conserved 8-residue sequence (KWPWY/WVWL) suppos-
edly important for membrane fusion but not, as we show
here, for S protein incorporation into particles. The other
area occurs in the membrane-proximal part of the CD. It
does not involve sequence conservation but, rather, the
conserved abundance of cysteines (about 24%). Our
carboxy-terminal truncations reveal that it is this particular
domain that mediates particle assembly of the coronaviral
spikes.
The S2 subunit of the S protein is known to be
palmitoylated (Bos et al., 1995; Niemann and Klenk,
1981; Schmidt, 1982; Sturman et al., 1985; van Berlo et
al., 1987), most likely through covalent acylation of one or
more cysteine residues in the cysteine-rich region of the CD.
Whether acylation is in some way important for S protein
assembly is unknown. Theoretical analysis using the
hydrophobicity scale (Eisenberg et al., 1982) predicts this
domain to form an amphipathic alpha-helix in which the
cysteine residues occur clustered on one side of the helix
(data not shown). It is conceivable that hydrophobic acyl
chains connected to the cysteines promote membrane
association of the alpha-helical domain by inserting into
the lipid bilayer. It is of note that an amphipathic region also
occurs in the carboxy-terminal domain of the M protein
(Rottier, 1995b). This domain has a strong tendency to
associate with membranes by itself (Mayer et al., 1988).
Mutation studies have shown that deletions in this domain
severely affect interaction of M with the S protein (de Haan
et al., 1999). It is thus feasible that incorporation of the S
protein into the coronaviral envelope is mediated by
interactions between the amphipathic domains of the two
proteins.
Besides for S protein incorporation into the viral
envelope the membrane-proximal region of the spike
protein is also of critical significance for the membrane
fusion function of the protein. Though clearly distinct
processes, the truncations in the spike CD affected both
features similarly, a short truncation having limited effect,
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bly and with fusion. The importance of the cysteine-rich
region for membrane fusion has already been established
before (Bos et al., 1995; Chang et al., 2000). It was shown
that a spike mutant from which part of the cysteine-rich
region had been deleted, was able to promote hemifusion,
but blocked in fusion pore formation. In addition, single
cysteine mutations severely impaired membrane fusion
activity (Chang et al., 2000). Whether this effect was due
to acylation being prevented is unclear but it is conceivable
that the membrane-inserted hydrophobic acyl chains play a
role in fusion pore formation. A positive role of palmitoy-
lation in cell fusion has been reported for influenza virus
HA protein (Naeve and Williams, 1990; Sakai et al., 2002),
but this role was found to be negative for VSV (Whitt and
Rose, 1991), influenza virus (Naim et al., 1992; Steinhauer
et al., 1991), or the Murine leukemia virus fusion protein
(Yang and Compans, 1996).
It appeared that the length of the S protein cytoplasmic
tail, rather than its sequence per se, is important for its
functioning in the context of the coronavirus. Introduction
of the cytoplasmically truncated S constructs into the viral
genome by targeted recombination yielded viable viruses
except, as expected, for the truncation affecting the fusion
function. While the lack of 12 cytoplasmic residues had a
quite marginal effect on viral growth, deletion of 25 residues
crippled the virus severely. Serial passaging of the latter
virus led to the emergence of revertants that had regained
fitness by a deletion generating an accidental 6-residue
extension of the cytoplasmic tail. That the approximately 3
logs higher titers obtained with these revertants were indeed
accounted for by this particular deletion rather than by the
occurrence of additional, compensating mutations in other
genes, notably in the M or E gene, was confirmed by
demonstrating that a recombinant virus carrying only this
mutation exhibited the same growth phenotype. The
sequence of the 6-amino acid extension appeared to have
no similarity to the deleted sequence suggesting that, for
some reason, a minimal tail length of about 20 residues is
required; shorter tails (i.e., removal of 18 residues or more)
are disproportionately detrimental. The observations are
reminiscent of findings with the rhabdovirus VSV which, as
mentioned above, shows reduced viral titers when the G
protein’s 29-residues cytoplasmic domain is removed. Upon
passaging of the tail-less recombinant virus a revertant
growing to wild-type levels was obtained, which encoded a
new 8 amino acid tail the sequence of which was unrelated
to that of the wild-type VSV G carboxy-terminal tail.Materials and methods
Virus, cells, and antibodies
Recombinant vaccinia virus encoding the bacteriophage
T7 RNA polymerase (vTF7-3) was obtained from Dr. B.Moss. OST7-1 cells (also from Dr. B. Moss) (Elroy-Stein
and Moss, 1990) and LR7 cells (Kuo et al., 2000) were
maintained as monolayer cultures in Dulbecco’s modified
Eagle’s medium (DMEM) containing 10% fetal calf serum
(FCS), 100 IU of penicillin/ml, and 100 Ag of streptomycin/
ml (from Life Technologies, Ltd.). Monoclonal antibody
(mAb) WA3.10 directed against the MHV S protein was
provided by Dr. J. Fleming (University of Wisconsin,
Madison, WI) (Weismiller et al., 1990). The production of
polyclonal antiserum K134 against MHV-A59 (anti-MHV)
(Rottier et al., 1981) and K114 against VSV (anti-VSV)
(Vennema et al., 1990) has been described.
Construction of expression vectors and recombinant
MHV-ERLM
All expression vectors contained the genes under the
control of the bacteriophage T7 transcription regulatory
elements. The expression constructs pTUMM, pTM5ab, and
pTUMS contain the MHV (strain A59) M, E, and S gene,
respectively, cloned into the pTUG3 plasmid (Vennema et
al., 1991, 1996). All newly generated junctions and PCR
amplified segments were verified by DNA sequencing.
Expression construct pTMFS, encoding the MFF hybrid
protein (see Fig. 1), contains the gene corresponding to the
ectodomain (ED) of MHV S and both the transmembrane
domain (TM) and the cytoplasmic domain (CD) of FIPV S
(Godeke et al., 2000a). The expression plasmid pTUG-
MFM-S, expressing the MFM chimera, contains the MHV S
gene in which the TM coding region is replaced by that of
FIPV S. The pTUG-MFM-S construct was constructed by
splicing overlap extension PCR (SOE-PCR). The TM
coding region of FIPV S and the CD coding region of
MHV S were PCR amplified using the inside primers 934
and 935 and the external primers 933 and 939 (Table 1). The
vectors pFIPVE2 (Godeke et al., 2000a) and pTFM-S,
respectively, were used as template in the first round of
PCR. The PCR products were purified, combined, and then
PCR amplified with the external primers. The product
obtained was cloned into the pNOTA/T7 shuttle vector
according to the Prime PCR Cloner procedure (5 PrimeY 3
Prime, Inc.); it was subsequently excised from the plasmid
using SpeI and SalI and cloned into the SpeI-SalI digested
pTUMS vector.
In mutant pTUG-MMF-S the sequence encoding the CD
of MHV-S was replaced by the corresponding sequence
from FIPV S. This construct, specifying the MMF hybrid
protein, was generated by SOE-PCR. The TM coding region
of MHV S and the CD coding region FIPV S were PCR
amplified using inside primers 936 and 937 and external
primers 933 and 938. The vectors pTMF-S and pFIPVE2,
respectively, were used as template in the first round of
PCR. Purified PCR products were mixed and a second
round of PCR was performed using the external primers 933
and 938. The resulting product was cloned into the shuttle
vector pNOTA/T7. This vector was subsequently digested
Table 1
Primers used for plasmid construction
Primer Sense Sequence (5V–3V)
933 + GAACTATGTATCAGCCTAGAGTTG
934  GAGCCACACCCTGTGCTAAAACAGC
935 + GTTTTAGCACAGGGTGTGGCTCATG
936  ACAACACCCTGTGCAGCAACATA
937 + GTTGCTGCACAGGGTGTGGATG
938  GGTCGACTTAGTGGACATGCACTTTTTC
939  GGTCGACTCAATCTTCATGAGAGGAAATATTATG
980  GCTCTAGAGTCGACTCAGTCCTGGTGTCCTCCATAC
981  GCTCTAGAGTCGACTCACTTCTTAAAACAACATGAGC
982  GCTCTAGAGTCGACTCAGCAGCAACATATAAAGAATAAC
1029 + GTAGTTGGAAGAGCTCTATTG
1030  GCGGATCCTTACTTTCCAAGTCGGTTC
1031 + GGATGAGCTCTAAATGGCCTTGGTATG
1032  GCGGATCCTCAATCCTCATGAGAGGAAATATTATG
1033  CAACAATTTCCACATCGGAGAACCAAGAATAG
1034 + CTTGGTTCTCCGATGTGGAAATTGTTGTGATG
1035 + CGCCTGTGATATCTACATCTG
1036 + AAATGGCCTTGGTATGTTTG
1037  CAATTTCCACATCCTGTGGTTGCAGTAAAG
1038 + CAACCACAGGATGTGGAAATTGTTGTGATG
1073  GTGCAGCAACATCGGAGAACCAAGAATAG
1074 + CTTGGTTCTCCGATGTTGCTGCACAGGTTG
1075  GTGCAGCAACATCCTGTGGTTGCAGTAAAG
1076 + CAACCACAGGATGTTGCTGCACAGGTTG
1090  GATTCAGGTTTGTAACATAATCTAGAGTCTTAGG
1261  GCTGCTTACTCCTATCATAC
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the StyI–SalI digested plasmid pTUMS.
The expression vectors pTMHVS-CDD12, pTMHVS-
CDD25, and pTMHVS-CDD35 carry MHV S genes with
increasing 3V-terminal truncations, thus specifying S pro-
teins with cytoplasmic domain truncations of 12, 25, and 38
amino acids, respectively. The constructs were generated by
PCR using the forward primer 933 and the reverse primer
980, 981, and 982, respectively. PCR products were treated
with StyI and SalI and cloned into the StyI–SalI digested
pTUMS vector.
The transcription vectors pXH2ERLM-SD12, -SD25,
and -SD35 were used for the construction of Renilla
luciferase expressing MHVs carrying S proteins with C-
terminal truncations of 12 (ERLM-SD12), 25 (ERLM-
SD25), and 35 residues (ERLM-SD35), respectively. The
pXH2ERLM vector was treated with Sse8387I, blunted
with T4 DNA polymerase and digested with MluI. The
plasmids pTMHVS-CDD12, pTMHVS-CDD25, and
pTMHVS-CDD35 were digested with Sal1, blunted with
T4 DNA polymerase and subsequently digested with MluI;
the purified MluI–Sal1 fragments were cloned into the
MluI–Sse8387I digested plasmid pXH2ERLM thereby
creating the pXH2ERLM-SD12, -SD25, and -SD35 vectors,
respectively.
S genes containing mutations in the CD were transferred
into the MHV genome by targeted RNA recombination as
described previously (de Haan et al., 2002; Hsue et al.,
2000). Capped, run-off donor RNAs transcribed from the
PacI-truncated transcription vectors were electroporatedinto feline FCWF cells that had been infected 4 h earlier
by fMHV (Kuo et al., 2000). These cells were then divided
over two T25 flasks containing a monolayer of LR7 cells, to
obtain two independent recombinant viruses (clones A and
B). Progeny viruses released into the media were harvested
and candidate recombinants were selected by two rounds of
plaque purification on LR7 cells. RT-PCR was used to
amplify regions of cytoplasmic RNA isolated from cells
infected with MHV-ERLM or MHV-ERLM-SD12 (clones A
and B) and MHV-ERLM-SD25 (clone B). The approximate
locations of primers 1036, 1090, and 1261 in the recombi-
nant MHV genomes are shown (Fig. 6B). RT-PCR was
performed on the MHV genomic RNA using primer 1261,
whereas the PCR was performed on the RT-PCR product
using primers 1036 and 1090. The PCR products obtained
were cloned into pGEM-T-Easy and sequenced. The
observed 17-nt deletion in the PCR product of the passaged
MHV-ERLM-SD25 revertant, which resulted in a 6-aa
extension of the S protein cytoplasmic domain, was re-
introduced into the MHV-ERLM genome. To this end, the
cloned RT-PCR product was digested with AccI and StyI
and the 450-bp fragment was cloned into the pBL59 vector
resulting in pBL59-SD25R. The transcription vector pXH2-
ERLM-SD25R, needed to produce donor RNA for the
construction of recombinant MHV-ERLM-SD25R via tar-
geted recombination, was created by ligation of the MluI–
EcoRV fragment of pBL59-SD25R into the MluI–EcoRV
digested pXH2-ERLM vector (Kuo et al., 2000). The final
construct was verified by DNA sequencing and recombinant
virus (MHV-ERLM-SD25R) was made as described above.
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derivative of pSVGL (Rose and Bergmann, 1982) using
XhoI. The DNA fragment was filled in with the Klenow
enzyme and ligated into the BamHI digested and Klenow
blunted pTUG31 linearized vector (Vennema et al., 1991)
yielding the pTUGVG10 plasmid. The fragment encoding
the VSV G ectodomain was excised from pSV045R-ts
(kindly provided by Dr. J.K. Rose) (Gallione and Rose,
1985) by using XhoI and SstI and cloned into pTUG31
treated with the same enzymes, resulting in the plasmid
pTVGtsDTMCD. The vector pTVGts-STC, encoding the
hybrid protein G-STC, contains the sequence encoding the
ectodomain of VSV G and the TM and CD of MHV S. A
DNA fragment specifying the TM and CD of MHV S was
PCR amplified from the plasmid pTUMS using the primers
1031 and 1032. The purified PCR product was treated with
SstI and BamHI and cloned into the SstI–BamHI digested
pTVGtsA¨TMCD vector. The vector pTVGts-SC, encoding
the hybrid proteins G-SC, contains the sequence for the
ectodomain and TM of VSV G fused to that for the C-
terminal 38 residues of MHV S. The pTVGts-SC construct
was prepared by SOE-PCR. The TM coding region of the
VSV G gene and the CD coding region of MHV S were
PCR amplified using the inside primers 1073 and 1074 and
the external primers 1029 and 1032, respectively. The
vectors pSV045R-ts and pTUMS, respectively, were used as
templates in the first round of PCR. Purified PCR products
were then mixed and a second round of PCR was performed
using the external primers 1029 and 1032. The resulting
PCR product was treated with SstI and BamHI and cloned
into the SstI–BamHI digested plasmid pTVGtsDTMCD.
Infection and transfection
Subconfluent monolayers of OST7-1 cells in 10 cm2
dishes were inoculated with vTF7.3 in DMEM at a
multiplicity of infection (MOI) of 10. After 1 h (t = 1 h)
cells were washed with DMEM and overlaid with trans-
fection medium that consisted of 0.2 ml DMEM containing
10 Al of lipofectin (Life Technologies) and 5 Ag of pTUMM,
1 Ag of pTM5ab, and 2 Ag of a third selected construct.
After 10 min at room temperature (RT), 0.8 ml of DMEM
was added and incubation was continued at 37 8C. At t = 2
h, cells were transferred to 32 8C.
Metabolic labeling and immunoprecipitation
At t = 4.5 h, cells were washed with DMEM and starved
for 30 min in cysteine- and methionine-free MEM contain-
ing 10 mM HEPES, pH 7.2, without FCS. The medium was
subsequently replaced by 600 Al of the same medium but
containing 100 ACi of 35S in vitro labeling mixture
(Amersham). At t = 6 h the radioactivity was chased by
incubating the cells with medium containing 2 mM
methionine and 2 mM cysteine. At t = 9 h cells were
placed on ice, and the media were collected and cleared bycentrifugation for 15 min at 4,000  g and 4 8C. The media
were prepared for immunoprecipitation in the absence or
presence of detergents, by addition of 2.5 volume of TEN
buffer (Tris pH 7.6, 1 mM EDTA, 50 mM NaCl) or 1/4
volume of 5 concentrated detergent buffer (final concen-
tration 50 mM Tris–Cl pH 8.0, 62.5 mM EDTA, 0.5%
sodium deoxycholate, 0.5% Nonidet P-40), respectively.
Cells were washed with ice-cold phosphate-buffered saline
containing Ca2+ and Mg2+ and lysed with 600 Al detergent
buffer containing 1 mM PMSF. The cell lysates were
cleared by centrifugation for 10 min at 10,000  g at 4 8C
and diluted five times with detergent buffer. Viral proteins in
the cell lysates and culture media were incubated overnight
(O/N) at 4 8C with the polyclonal MHV-A59 antiserum (2
Al), the polyclonal VSV antiserum (2 Al), the mAb WA3.10
(20 Al), and the mAb OKT8 (50 Al). The immune complexes
were adsorbed to Pansorbin cells (Calbiochem) for 30 min
at 4 8C and were subsequently collected by low-speed
centrifugation. Pellets were washed three times by resus-
pension and centrifugation with either detergent buffer or
TEN buffer. Pellets were resuspended and heated in
Laemmli sample buffer at 95 8C for 2 min before being
analyzed by SDS–PAGE in 15% polyacrylamide gels.
Cell–cell fusion assay
Subconfluent monolayers of OST7-1 cells in 10 cm2
dishes were inoculated with vTF7.3 in DMEM at an MOI of
10. At t = 1 h cells were washed with DMEM and medium
was replaced with transfection medium that consisted of 0.2
ml DMEM containing 10 Al of lipofectin (Life Technolo-
gies) and 4 Ag of the various MHV S constructs. After 10
min at RT, 0.8 ml of DMEM was added and incubation was
continued at 37 8C. At t = 3 h cells were washed with
DMEM and overlaid with LR7 cells (1:2 ratio). At t = 10 h
photographs of the cells were taken under an inverted light
microscope at 40 magnification.Acknowledgments
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